Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Moskop, A; Pommert, L; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; Talano, JA; Margossian, SP; Verneris, MR; Myers, GD; Karras, NA; Brown, PA; Qayed, M; Hermiston, ML; Satwani, P; Krupski, C; Keating, AK; Wilcox, R; Rabik, CA; Fabrizio, VA; Chinnabhandar, V; Goksenin, AY; Curran, KJ; Mackall, CL; Laetsch, TW; Guest, EM; Breese, EH; Schultz, LM

Moskop, A (通讯作者)，Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol Blood & Marrow Transplantat, 8701 W Watertown Plank Rd,MFRC 3018, Milwaukee, WI 53226 USA.;Moskop, A (通讯作者)，Childrens Wisconsin, 8701 W Watertown Plank Rd,MFRC 3018, Milwaukee, WI 53226 USA.

BLOOD ADVANCES, 2022; 6 (14): 4251

Abstract

Infants with B-cell acute lymphoblastic leukemia (B-ALL) have poor outcomes because of chemotherapy resistance leading to high relapse rates. Tisagenl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索